| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/01/2002 | CA2109602C Methods for producing members of specific binding pairs |
| 10/01/2002 | CA2103546C Modified factor vii |
| 10/01/2002 | CA2080482C Isolated promoter and terminator of elongation factor ef-1.alpha. |
| 10/01/2002 | CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them |
| 10/01/2002 | CA2075209C Virus/herbicide resistance genes process for producing same and their use |
| 10/01/2002 | CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection |
| 10/01/2002 | CA2011304C Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe |
| 10/01/2002 | CA1341390C Human protein disulfide isomerase polypeptide and dna encoding the same |
| 10/01/2002 | CA1341389C Human granulocyte colony stimulating factor |
| 09/30/2002 | CA2380047A1 Methods for genomic analysis |
| 09/28/2002 | CA2340792A1 Method and system for evolutionary phenogenetic engineering |
| 09/28/2002 | CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 09/26/2002 | WO2002075569A1 Encapsulating fibre channel signals for transmission over non-fibre channel networks |
| 09/26/2002 | WO2002075507A2 Anti-bacterial vaccine compositions |
| 09/26/2002 | WO2002075317A2 Screening for drugs against disorders associated with schizophrenia |
| 09/26/2002 | WO2002075306A1 Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications |
| 09/26/2002 | WO2002075304A1 Method of examining allergic disease |
| 09/26/2002 | WO2002075275A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | WO2002074996A1 Gene regulation |
| 09/26/2002 | WO2002074995A1 Method for alteration detection |
| 09/26/2002 | WO2002074990A1 Molecular target validation method |
| 09/26/2002 | WO2002074989A2 Disease associated polymorphism in the ctla-4 locus |
| 09/26/2002 | WO2002074987A2 Quantitative diagnostic analysis of hypertonia |
| 09/26/2002 | WO2002074986A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | WO2002074982A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states |
| 09/26/2002 | WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 09/26/2002 | WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | WO2002074979A2 Expression profiles and methods of use |
| 09/26/2002 | WO2002074978A2 Nucleic acid shuffling |
| 09/26/2002 | WO2002074977A2 Sugar and lipid metabolism regulators in plants |
| 09/26/2002 | WO2002074969A2 Matrix attachment regions and methods for use thereof |
| 09/26/2002 | WO2002074968A1 Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof |
| 09/26/2002 | WO2002074967A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 09/26/2002 | WO2002074966A2 Process for the preparation of l-amino acids by using coryneform bacteria |
| 09/26/2002 | WO2002074965A2 Characterization of the i-spoml endonuclease from fission yeast |
| 09/26/2002 | WO2002074964A2 Polypeptides derived from rna polymerases and use thereof |
| 09/26/2002 | WO2002074963A1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 09/26/2002 | WO2002074962A1 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 09/26/2002 | WO2002074961A1 Novel nucleic acids and polypeptides |
| 09/26/2002 | WO2002074960A2 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
| 09/26/2002 | WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 09/26/2002 | WO2002074958A1 Yeast transformed with cdna of deer velvet antler for the production of efficient pharmacological ingredients and the preparation of the transformed yeast |
| 09/26/2002 | WO2002074957A2 Stress-responsive activator of p300 (strap) protein |
| 09/26/2002 | WO2002074956A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | WO2002074955A2 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof |
| 09/26/2002 | WO2002074954A1 Method for isolating plasmids from suspended bacterial or yeast cells |
| 09/26/2002 | WO2002074953A2 Gene library and a method for producing the same |
| 09/26/2002 | WO2002074952A2 Nucleic acid which is stabilised against decomposition |
| 09/26/2002 | WO2002074950A1 Method of analyzing intermolecular interaction |
| 09/26/2002 | WO2002074949A1 Preparation of calibrants and use thereof in the quantification of nucleotide sequences of interest |
| 09/26/2002 | WO2002074948A2 Animal tissue with carbohydrate antigens compatible for human transplantation |
| 09/26/2002 | WO2002074947A2 Method for homologous recombination using the genes bet and exo, but not gam, of the lambda recombination system |
| 09/26/2002 | WO2002074945A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | WO2002074944A1 Process for the preparation of l-amino acids by using coryneform bacteria |
| 09/26/2002 | WO2002074943A2 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains |
| 09/26/2002 | WO2002074942A2 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 09/26/2002 | WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 09/26/2002 | WO2002074935A2 Use of telomerase reverse transcriptase to create homozygous knockout animals |
| 09/26/2002 | WO2002074930A2 Trans inteins for protein domain shuffling and biopolymerization |
| 09/26/2002 | WO2002074929A2 Evolving new molecular function |
| 09/26/2002 | WO2002074928A2 Fusion peptides isolatable by phase transition |
| 09/26/2002 | WO2002074926A2 Myo-inositol oxygenases |
| 09/26/2002 | WO2002074920A2 A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same |
| 09/26/2002 | WO2002074917A2 Method for modifying a biological pathway |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074909A2 Cell cycle nucleic acids, polypeptides and uses thereof |
| 09/26/2002 | WO2002074905A2 Leptin induced genes |
| 09/26/2002 | WO2002074904A2 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | WO2002074903A2 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 09/26/2002 | WO2002074810A2 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/26/2002 | WO2002074808A2 Modified insulin with reduced immunogenicity |
| 09/26/2002 | WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074805A1 Soluble rage protein |
| 09/26/2002 | WO2002074803A2 Regulation of human icos v protein |
| 09/26/2002 | WO2002074802A2 Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 09/26/2002 | WO2002074801A1 An osmotic stress-inducible protein functioning as a negative regulator in osmotic stress signaling pathway of plants |
| 09/26/2002 | WO2002074800A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | WO2002074799A2 Pepsin-sensitive modified bacillus thuringiensis insecticidal toxin |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074796A2 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | WO2002074795A2 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 09/26/2002 | WO2002074794A2 Compositions useful in gene therapy |
| 09/26/2002 | WO2002074787A2 Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules |
| 09/26/2002 | WO2002074783A2 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | WO2002074326A2 Urocortin-iii and uses thereof |
| 09/26/2002 | WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 09/26/2002 | WO2002074251A2 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 09/26/2002 | WO2002074239A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | WO2002074237A2 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 09/26/2002 | WO2002074230A2 A dna molecule encoding a variant paraoxonase and uses thereof |
| 09/26/2002 | WO2002074157A2 A mammalian immortalized liver cell |
| 09/26/2002 | WO2002074156A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 09/26/2002 | WO2002074078A2 Method for embryo after impregnation of the recipient female |
| 09/26/2002 | WO2002074071A2 Transgenic animal model of ige-mediated allergic responses |
| 09/26/2002 | WO2002074048A2 P-glycoproteins and uses thereof |
| 09/26/2002 | WO2002074045A2 Production of pancreatic islet cells and delivery of insulin |